Product image of Octanine (Human Coagulation Factor Ix) supplied by GNH India

Octanine

Active Ingredient:
Human Coagulation Factor Ix
Origin:
EU

Octanine (Human Coagulation Factor Ix)

Human Coagulation Factor IX, the active ingredient in Octanine, is a coagulation factor replacement therapy presented as a sterile injectable solution for intravenous use. It replaces deficient factor IX to manage bleeding in patients with hemophilia B. GNH India supplies Octanine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Octapharma (Ip) Sprl

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Octanine is used in the management of hemophilia B and related bleeding disorders.

  • Hemophilia B: provides factor IX replacement to control and prevent bleeding episodes.
  • Surgical procedures in hemophilia B patients: ensures adequate hemostasis during and after surgery.
  • Prophylactic therapy for hemophilia B: reduces the frequency of spontaneous bleeds and improves quality of life.

How It Works

  • Human Coagulation Factor IX acts as a key component of the intrinsic pathway of the coagulation cascade. When administered, it binds to activated factor VIII on phospholipid surfaces, forming a complex that activates factor X to Xa, leading to thrombin generation and fibrin clot formation, thereby restoring normal hemostasis in factor IX‑deficient individuals.

Side Effects

Octanine may be associated with several adverse reactions following infusion.

Common Side Effects

  • Infusion site reactions: redness, swelling, or pain at the injection site.
  • Fever or chills during or after administration.
  • Headache or mild dizziness.
  • Nausea or abdominal discomfort.
  • Arthralgia or joint pain.
  • Transient increase in liver enzymes.

Serious or Rare Side Effects

  • Anaphylactic or severe allergic reactions.
  • Development of neutralizing antibodies (inhibitors) against factor IX.
  • Thrombotic events such as deep vein thrombosis.
  • Viral transmission risk from biologic product.
  • Severe hemolysis or renal impairment.
  • Unexpected bleeding despite therapy.

Precautions & Warnings

Before using Octanine, certain precautions should be observed.

  • Inhibitor monitoring: regularly assess for development of anti‑factor IX antibodies.
  • Infection screening: ensure donor-derived product is free from viral contaminants.
  • Hypersensitivity: avoid in patients with known allergy to factor IX or excipients.
  • Concomitant anticoagulants: adjust therapy to prevent over‑ or under‑coagulation.
  • Pediatric and elderly patients: monitor dosing and response closely.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Octanine can interact with other agents affecting coagulation.

Major Interactions (Avoid)

  • Concurrent use of other pro‑coagulant factor concentrates may increase thrombosis risk.
  • Simultaneous administration of high‑dose anticoagulants (e.g., warfarin) can negate therapeutic effect.

Moderate Interactions (Monitor Closely)

  • Use with antifibrinolytic agents (e.g., tranexamic acid) requires monitoring for excessive clot formation.
  • Combination with immunosuppressive drugs may influence inhibitor development.
  • Co‑administration with heparin may require dose adjustments and coagulation monitoring.

Frequently Asked Questions

Octanine is a biologic product that provides human coagulation factor IX to replace the deficient clotting factor in patients with hemophilia B, helping to control bleeding episodes, support surgical procedures, and serve as prophylactic therapy.

The factor IX protein participates in the intrinsic coagulation cascade. After infusion, it binds to activated factor VIII, forming a complex that activates factor X, leading to thrombin generation and fibrin clot formation, thereby restoring normal hemostasis.

The specific dose of Octanine is determined by the prescribing clinician based on the patient’s severity of factor IX deficiency, weight, bleeding history, and the clinical situation. Dosing regimens are individualized and not standardized.

Safety data for Octanine in pregnancy and lactation are limited. Use is generally reserved for pregnant or nursing patients only when the potential benefit justifies any potential risk, and it should be prescribed by a specialist familiar with hemophilia management.

To order Octanine, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if required), and import documentation.

Octanine is a recombinant or plasma‑derived factor IX concentrate comparable to other licensed factor IX therapies. Differences may include source (recombinant vs plasma), specific activity, stabilizers, and storage requirements. Clinical efficacy is similar, but selection often depends on availability, cost, and patient‑specific considerations.

Octanine must be stored at 2‑8 °C in a refrigerator, protected from light. Do not freeze or shake the vial. Before use, allow the product to reach room temperature if required, and inspect for particulate matter or discoloration.

Octanine is given by intravenous infusion. The rate and volume are determined by the prescribing clinician. Administration should be performed under aseptic conditions, typically in a clinical setting equipped for monitoring coagulation parameters.

Serious risks include the development of neutralizing antibodies (inhibitors) that reduce efficacy, severe allergic or anaphylactic reactions, thrombotic events such as deep vein thrombosis, and the theoretical risk of viral transmission from biologic products.

Octanine should not be used in individuals with known hypersensitivity to factor IX or any of its excipients, and caution is advised in patients with a history of inhibitor development. It is also contraindicated in patients where the risk of thrombosis outweighs the benefit of factor replacement.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Human Coagulation Factor Ix

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT